Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report

Authors: Pierre Emmanuel Charles, Emmanuel Kus, Serge AHO, Sébastien Prin, Jean-Marc Doise, Nils-Olivier Olsson, Bernard Blettery, Jean-Pierre Quenot

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

The usefulness of procalcitonin (PCT) measurement in critically ill medical patients with suspected nosocomial infection is unclear. The aim of the study was to assess PCT value for the early diagnosis of bacterial nosocomial infection in selected critically ill patients.

Methods

An observational cohort study in a 15-bed intensive care unit was performed. Seventy patients with either proven (n = 47) or clinically suspected but not confirmed (n = 23) nosocomial infection were included. Procalcitonin measurements were obtained the day when the infection was suspected (D0) and at least one time within the 3 previous days (D-3 to D0). Patients with proven infection were compared to those without. The diagnostic value of PCT on D0 was determined through the construction of the corresponding receiver operating characteristic (ROC) curve. In addition, the predictive value of PCT variations preceding the clinical suspicion of infection was assessed.

Results

PCT on D0 was the best predictor of proven infection in this population of ICU patients with a clinical suspicion of infection (AUROCC = 0.80; 95% CI, 0.68–0.91). Thus, a cut-off value of 0.44 ng/mL provides sensitivity and specificity of 65.2% and 83.0%, respectively. Procalcitonin variation between D-1 and D0 was calculated in 45 patients and was also found to be predictive of nosocomial infection (AUROCC = 0.89; 95% CI, 0.79–0.98) with a 100% positive predictive value if the +0.26 ng/mL threshold value was applied. Comparable results were obtained when PCT variation between D-2 and D0, or D-3 and D0 were considered. In contrast, CRP elevation, leukocyte count and fever had a poor predictive value in our population.

Conclusion

PCT monitoring could be helpful in the early diagnosis of nosocomial infection in the ICU. Both absolute values and variations should be considered and evaluated in further studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Digiovine B, Chenoweth C, Watts C, Higgins M: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999, 160: 976-981.CrossRefPubMed Digiovine B, Chenoweth C, Watts C, Higgins M: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999, 160: 976-981.CrossRefPubMed
2.
go back to reference Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in europe. Results of the european prevalence of infection in intensive care (EPIC) study. EPIC international advisory committee. JAMA. 1995, 274: 639-644. 10.1001/jama.274.8.639.CrossRefPubMed Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in europe. Results of the european prevalence of infection in intensive care (EPIC) study. EPIC international advisory committee. JAMA. 1995, 274: 639-644. 10.1001/jama.274.8.639.CrossRefPubMed
3.
go back to reference Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H: Risk factors for death due to nosocomial infection in intensive care unit patients: Findings from the krankenhaus infektions surveillance system. Infect Control Hosp Epidemiol. 2007, 28: 466-472. 10.1086/510810.CrossRefPubMed Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H: Risk factors for death due to nosocomial infection in intensive care unit patients: Findings from the krankenhaus infektions surveillance system. Infect Control Hosp Epidemiol. 2007, 28: 466-472. 10.1086/510810.CrossRefPubMed
4.
go back to reference Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D: Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003, 115: 529-535. 10.1016/j.amjmed.2003.07.005.CrossRefPubMed Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D: Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003, 115: 529-535. 10.1016/j.amjmed.2003.07.005.CrossRefPubMed
5.
go back to reference Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, Geest van der S, de Leeuw PW, Stobberingh EE: Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Antimicrob Chemother. 1997, 39: 527-535. 10.1093/jac/39.4.527.CrossRefPubMed Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, Geest van der S, de Leeuw PW, Stobberingh EE: Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Antimicrob Chemother. 1997, 39: 527-535. 10.1093/jac/39.4.527.CrossRefPubMed
6.
go back to reference Christ-Crain M, Muller B: Procalcitonin in bacterial infections – hype, hope, more or less?. Swiss Med Wkly. 2005, 135: 451-460.PubMed Christ-Crain M, Muller B: Procalcitonin in bacterial infections – hype, hope, more or less?. Swiss Med Wkly. 2005, 135: 451-460.PubMed
7.
go back to reference Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006, 34: 2596-2602. 10.1097/01.CCM.0000239116.01855.61.CrossRefPubMed Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006, 34: 2596-2602. 10.1097/01.CCM.0000239116.01855.61.CrossRefPubMed
8.
go back to reference Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut. 1997, 41: 832-840.CrossRefPubMedPubMedCentral Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut. 1997, 41: 832-840.CrossRefPubMedPubMedCentral
9.
go back to reference Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK: Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: A prospective, international multicenter study. Arch Surg. 2007, 142: 134-142. 10.1001/archsurg.142.2.134.CrossRefPubMed Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK: Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: A prospective, international multicenter study. Arch Surg. 2007, 142: 134-142. 10.1001/archsurg.142.2.134.CrossRefPubMed
10.
go back to reference Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, Riou B, Bernard M, Hausfater P: Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med. 2008, 36: 1147-1154. 10.1097/CCM.0b013e3181692966.CrossRefPubMed Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, Riou B, Bernard M, Hausfater P: Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med. 2008, 36: 1147-1154. 10.1097/CCM.0b013e3181692966.CrossRefPubMed
11.
go back to reference Siassi M, Riese J, Steffensen R, Meisner M, Thiel S, Hohenberger W, Schmidt J: Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care. 2005, 9: R483-489. 10.1186/cc3768.CrossRefPubMedPubMedCentral Siassi M, Riese J, Steffensen R, Meisner M, Thiel S, Hohenberger W, Schmidt J: Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care. 2005, 9: R483-489. 10.1186/cc3768.CrossRefPubMedPubMedCentral
12.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-874. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-874.
13.
go back to reference Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM: Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "Blind" Bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991, 143: 1121-1129.CrossRefPubMed Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM: Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "Blind" Bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991, 143: 1121-1129.CrossRefPubMed
14.
go back to reference Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med. 2008, 34: 1434-40. 10.1007/s00134-008-1112-x.CrossRefPubMed Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med. 2008, 34: 1434-40. 10.1007/s00134-008-1112-x.CrossRefPubMed
15.
go back to reference Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med. 2006, 34: 102-107. 10.1097/01.CCM.0000195012.54682.F3.CrossRefPubMed Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med. 2006, 34: 102-107. 10.1097/01.CCM.0000195012.54682.F3.CrossRefPubMed
16.
go back to reference Charles PE, Ladoire S, Snauwaert A, Prin S, Aho S, Péchinot A, Olsson NO, Blettery B, Doise JM, Quenot JP: Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis. 2008, 8: 163-10.1186/1471-2334-8-163.CrossRefPubMedPubMedCentral Charles PE, Ladoire S, Snauwaert A, Prin S, Aho S, Péchinot A, Olsson NO, Blettery B, Doise JM, Quenot JP: Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis. 2008, 8: 163-10.1186/1471-2334-8-163.CrossRefPubMedPubMedCentral
17.
go back to reference Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, Menendez R, Asenjo MA, Torres A: Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J. 2008, 31: 356-362. 10.1183/09031936.00086707.CrossRefPubMed Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, Menendez R, Asenjo MA, Torres A: Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J. 2008, 31: 356-362. 10.1183/09031936.00086707.CrossRefPubMed
18.
go back to reference Charles PE, Dalle F, Aho S, Quenot JP, Doise JM, Aube H, Olsson NO, Blettery B: Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med. 2006, 32: 1577-1583. 10.1007/s00134-006-0306-3.CrossRefPubMed Charles PE, Dalle F, Aho S, Quenot JP, Doise JM, Aube H, Olsson NO, Blettery B: Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med. 2006, 32: 1577-1583. 10.1007/s00134-006-0306-3.CrossRefPubMed
19.
go back to reference Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, Olsson NO, Blettery B: Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis. 2008, 8: 38-10.1186/1471-2334-8-38.CrossRefPubMedPubMedCentral Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, Olsson NO, Blettery B: Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis. 2008, 8: 38-10.1186/1471-2334-8-38.CrossRefPubMedPubMedCentral
20.
go back to reference Schurink CA, Van Nieuwenhoven CA, Jacobs JA, Rozenberg-Arska M, Joore HC, Buskens E, Hoepelman AI, Bonten MJ: Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004, 30: 217-224. 10.1007/s00134-003-2018-2.CrossRefPubMed Schurink CA, Van Nieuwenhoven CA, Jacobs JA, Rozenberg-Arska M, Joore HC, Buskens E, Hoepelman AI, Bonten MJ: Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004, 30: 217-224. 10.1007/s00134-003-2018-2.CrossRefPubMed
21.
go back to reference Luyt CE, Chastre J, Fagon JY: Value of the clinicalpulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004, 30: 735-738. 10.1007/s00134-003-2125-0.CrossRef Luyt CE, Chastre J, Fagon JY: Value of the clinicalpulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004, 30: 735-738. 10.1007/s00134-003-2125-0.CrossRef
Metadata
Title
Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report
Authors
Pierre Emmanuel Charles
Emmanuel Kus
Serge AHO
Sébastien Prin
Jean-Marc Doise
Nils-Olivier Olsson
Bernard Blettery
Jean-Pierre Quenot
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-49

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.